The impact of FDG PET on the management of occult primary head and neck tumours. The aim of this study was to investigate the impact of positron-emission tomography (PET) with 18F-labelled fluoro-2-deoxy-D-glucose (FDG) in the management of occult primary head and neck tumours.We reviewed 16 patients with squamous cell carcinoma (SCC) and one patient with undifferentiated carcinoma of cervical lymph nodes (N1-4 N2a-9FDG PET suggested a primary site in eight of the 17 patients (tongue base 5 nasopharynx 1